Roberts R O, Lynch C F, Jones M P, Hart M N
Department of Preventive Medicine, University of Iowa, Iowa City 52242.
J Neuropathol Exp Neurol. 1991 Mar;50(2):134-44. doi: 10.1097/00005072-199103000-00005.
Five hundred thirty-two cases of medulloblastoma (males n = 327 and females n = 205), aged 0 to 86 years diagnosed between 1973 and 1986 were studied to determine the incidence in different geographic regions of the United States and to evaluate the effect of various factors on survival. The median age was 9 years and average follow-up time was 45 months. The overall incidence rate was 1.8 per one million person-years. Variables that were statistically significant (p less than 0.05) in a multivariate model determining survival in rank order were treatment group, sex, geographic region, year group and age. This observational study found that 1) age and sex were statistically significant factors in describing the incidence rates, whereas year group and geographic region were not; 2) no incidence peak in the third decade of life was observed; 3) a significant improvement in survival was observed in the combined 1978 to 1986 year groups relative to the 1973 to 1977 year group; 4) the overall 5-year survival probability was 45%; and 5) there has been an increase over time in the use of more than two modalities of treatment.
对1973年至1986年间诊断出的532例髓母细胞瘤患者(男性n = 327,女性n = 205)进行了研究,这些患者年龄在0至86岁之间,旨在确定美国不同地理区域的发病率,并评估各种因素对生存率的影响。中位年龄为9岁,平均随访时间为45个月。总体发病率为每100万人年1.8例。在多变量模型中,按重要性排序对生存率有统计学显著意义(p小于0.05)的变量依次为治疗组、性别、地理区域、年份组和年龄。这项观察性研究发现:1)年龄和性别是描述发病率的统计学显著因素,而年份组和地理区域则不是;2)未观察到生命第三个十年出现发病率高峰;3)相对于1973年至1977年组,1978年至1986年组的生存率有显著提高;4)总体5年生存概率为45%;5)随着时间推移,使用两种以上治疗方式的情况有所增加。